Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ingrid H.E. Korenromp"'
Publikováno v:
European Respiratory Review, Vol 29, Iss 155 (2020)
Aims Many sarcoidosis patients experience a reduction in health-related quality of life (HRQoL) and a majority of patients report fatigue. Historically, drug trials in sarcoidosis have focused on changes in chest radiographs, lung function parameters
Externí odkaz:
https://doaj.org/article/e6dc67cc006841a49b22baadbf29b52e
Publikováno v:
Sarcoidosis and other granulomatous ILD/DPLD.
Many patients with pulmonary sarcoidosis experience reduced quality of life. Although oral corticosteroids are the most common agents used in sarcoidosis, very little is known on the effects on quality of life. We evaluated the efficacy of low dose o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c818712170a298ee5a63452a0637a13f
https://doi.org/10.1183/13993003.congress-2018.pa5206
https://doi.org/10.1183/13993003.congress-2018.pa5206
Autor:
Ingrid H.E. Korenromp, Coline H.M. van Moorsel, Jan C. Grutters, Vera H.M. Deneer, Adriane D.M. Vorselaars, Heleen A. Crommelin
Publikováno v:
Immunotherapy. 6:1127-1143
Sarcoidosis is a systemic disease with an incidence of 1 to 40 per 100 000 persons per year. It predominantly affects people in the age of 20 to 40 years old. Disease course varies from mild self-limiting to chronic debilitating and life-threatening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd8632e9185e1f8fb25580d0393572ac
https://doi.org/10.2217/imt.14.65
https://doi.org/10.2217/imt.14.65
Publikováno v:
Current opinion in pulmonary medicine, 20(5), 503-507. Lippincott Williams and Wilkins
Purpose of review: The review presents an overview of the scientific publications in the field of health-related quality of life (HRQL) in sarcoidosis. Recent findings: Literature on HRQL in sarcoidosis is limited. HRQL was mainly used as a primary o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc653544654e40b474c15e04ad0756d4
https://doi.org/10.1097/mcp.0000000000000079
https://doi.org/10.1097/mcp.0000000000000079
Autor:
Ruth G.M. Keijsers, Ingrid H.E. Korenromp, Henk J.T. Ruven, Adriane D.M. Vorselaars, Pieter Zanen, Henricus Naj van Rijswijk, Jan C. Grutters
Publikováno v:
Expert Opinion on Orphan Drugs. 1:437-443
Objectives: The effect of infliximab therapy in rheumatoid arthritis and Crohn's disease has been well documented. However, literature on infliximab therapy in the rare disease sarcoidosis is scarce. The aim of our study is to evaluate change in dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bff8ab9fe0f189f4583fa8421f261b2
https://doi.org/10.1517/21678707.2013.797891
https://doi.org/10.1517/21678707.2013.797891
Autor:
Jan C. Grutters, Vera H.M. Deneer, Ingrid H.E. Korenromp, Adriane D.M. Vorselaars, Coline H.M. van Moorsel, Heleen A. Crommelin
Publikováno v:
Immunotherapy. 7(6)
A letter in response to: Banse C, Goëb V. Do not forget the joint involvement of sarcoidosis. Immunotherapy 7(6), 599–600 (2015).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e899657da170ff60d8b79e186bf47b2
https://pubmed.ncbi.nlm.nih.gov/26098193
https://pubmed.ncbi.nlm.nih.gov/26098193
Publikováno v:
Seminars in respiratory and critical care medicine. 35(3)
Fluorodeoxyglucose (FDG), labeled with a positron emitting fluorine-18 ((18)F), is a synthesized glucose analogue and is well known for its application in a wide variety of clinical conditions such as cancer. Visualizing metabolic activity of inflamm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6187ad54e9dc535e6c91011496c5a372
https://pubmed.ncbi.nlm.nih.gov/25007087
https://pubmed.ncbi.nlm.nih.gov/25007087
Autor:
Jan C. Grutters, S.N. de Haan, Ingrid H.E. Korenromp, F.J.J. van den Elshout, A.W.E. Braam, Adriane D.M. Vorselaars, Ger T. Rijkers
Publikováno v:
Brain, behavior, and immunity. 33
Fatigue in the immune mediated inflammatory disease sarcoidosis is thought to be associated with impaired exercise tolerance. This prospective study assessed fatigue and recuperative capacity after repeated exercise, and examined whether changing con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a5d708c7092c1258b37f34af91595ef
https://pubmed.ncbi.nlm.nih.gov/23727274
https://pubmed.ncbi.nlm.nih.gov/23727274
Autor:
Cobi Jacoba Johanna Heijnen, Jan C. Grutters, Ingrid H.E. Korenromp, Pieter Zanen, Annemieke Kavelaars, Jules M.M. van den Bosch
Publikováno v:
Brain, behavior, and immunity. 25(7)
When the inflammatory phase of sarcoidosis has resolved, complaints of chronic fatigue frequently persist. Low-grade residual inflammatory activity may play a role in maintaining chronic fatigue. The aim of this study was to compare in vitro cytokine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7349d7842b2dc2c972f90062e5d56b82
https://pubmed.ncbi.nlm.nih.gov/21693184
https://pubmed.ncbi.nlm.nih.gov/21693184